These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36204087)

  • 1. Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana.
    Peprah Boaitey K; Tuck C
    Med Access Point Care; 2020; 4():2399202620962299. PubMed ID: 36204087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review.
    Sorato MM; Davari M; Kebriaeezadeh A
    J Med Access; 2024; 8():27550834241236598. PubMed ID: 38476401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
    Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
    Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
    Pisani E; Nistor AL; Hasnida A; Parmaksiz K; Xu J; Kok MO
    Wellcome Open Res; 2019; 4():70. PubMed ID: 31131333
    [No Abstract]   [Full Text] [Related]  

  • 5. Tackling the blind spot of poor-quality medicines in Universal Health Coverage.
    Orubu ESF; Ching C; Zaman MH; Wirtz VJ
    J Pharm Policy Pract; 2020; 13():40. PubMed ID: 32670594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.
    Olliaro E; Olliaro P; Ho CWL; Ravinetto R
    Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients Access to Medicines - A Critical Review of the Healthcare System in Kenya.
    Toroitich AM; Dunford L; Armitage R; Tanna S
    Risk Manag Healthc Policy; 2022; 15():361-374. PubMed ID: 35256867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.
    Rasheed H; Höllein L; Holzgrabe U
    Front Pharmacol; 2018; 9():995. PubMed ID: 30233373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falsified and substandard medicines trafficking: A wakeup call for the African continent.
    Wada YH; Abdulrahman A; Ibrahim Muhammad M; Owanta VC; Chimelumeze PU; Khalid GM
    Public Health Pract (Oxf); 2022 Jun; 3():100240. PubMed ID: 36101748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.
    Kaplan WA; Cellini CM; Eghan K; Pilz K; Harrison D; Wirtz VJ
    J Pharm Policy Pract; 2023 May; 16(1):60. PubMed ID: 37131256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of medicine quality in achieving universal health coverage.
    Ozawa S; Higgins CR; Yemeke TT; Nwokike JI; Evans L; Hajjou M; Pribluda VS
    PLoS One; 2020; 15(7):e0232966. PubMed ID: 32645019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia.
    Mengesha A; Bastiaens H; Ravinetto R; Gibson L; Dingwall R
    Soc Sci Med; 2024 May; 349():116882. PubMed ID: 38669893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.
    Akpobolokemi T; Martinez-Nunez RT; Raimi-Abraham BT
    J Med Access; 2022; 6():23992026211070406. PubMed ID: 36204519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review.
    Melia E; English A; Naughton BD
    Front Med (Lausanne); 2024; 11():1429872. PubMed ID: 39091292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.